Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Solar3D Off to a Fast Start in 2014

Marketwired January 8, 2014

Spinomix Announces a Milestone Payment from Debiopharm Group(TM)and the Appointment of a new CEO

PR Newswire January 8, 2014

Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research

Thomson Reuters ONE January 8, 2014

Roche announces launch of the cobas® HSV 1 and 2 Test for herpes simplex virus in markets accepting the CE mark

PR Newswire January 8, 2014

Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research

Globe Newswire January 8, 2014

NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism

Business Wire January 7, 2014

Vestaron Corp. Appoints Dr. John Sorenson as CEO

Marketwired January 7, 2014

Insight Genetics Awarded New National Cancer Institute Contract to Identify Resistance Mutations in Lung Cancer Patients

Business Wire January 7, 2014

Bioniche Life Sciences Inc. Appoints a Chief Operating Officer

Canada NewsWire January 7, 2014

Intrexon to Present at the 2014 J.P. Morgan Healthcare Conference

PR Newswire January 7, 2014

Harper Government Boosts Winter Wheat Research

Marketwired January 7, 2014

Myriad Genetics to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Globe Newswire January 7, 2014

Red Hat and the CentOS Project Join Forces to Speed Open Source Innovation

Business Wire January 7, 2014

Lipocine Announces New Appointments to Its Board of Directors

Globe Newswire January 7, 2014

Blueprint Medicines Announces $25 Million Series B Financing

Business Wire January 7, 2014

Positive Results Presented from Phase 2 Clinical Trial of Biothera's Imprime PGG Cancer Immunotherapy in Non-Small Lung Cancer Patients

Business Wire January 7, 2014

2014 Community Awards Honor University, Industry, CDC Leaders

Business Wire January 7, 2014

Research and Markets: National Innovation Ecosystems (IT and Electronics) - Technical Insights

Business Wire January 7, 2014

Biomodels, LLC and Numira Inc Sign Joint Services Agreement

PR Newswire January 7, 2014

ExThera Medical's Seraph® Microbind® Affinity Blood Filter - An Investigational Device-Based Therapy for the Treatment of Bloodstream Infections

Business Wire January 7, 2014